Ryoji Nishibata

Title: Ryoji Nishibata: Innovator in Pharmaceutical Research

Introduction

Ryoji Nishibata is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the study of bronchial asthma and allergic rhinitis. With a total of 2 patents, his work has implications for the development of effective treatments for these conditions.

Latest Patents

Nishibata's latest patents include an "Agent for hypoalbuminaemia" and "Models for asthma guinea pig." The latter patent describes a method of preparing bronchial hypersensitive or hyposensitive guinea pigs through selective breeding based on their sensitivity to inhalant chemicals that induce bronchoconstriction. These hypersensitive guinea pigs serve as valuable model animals for studying bronchial asthma and allergic rhinitis, as well as for evaluating the efficacy of anti-asthmatics and antiallergic substances.

Career Highlights

Ryoji Nishibata is associated with Nippon Zoki Pharmaceutical Co., Ltd., where he has been instrumental in advancing research in his field. His innovative approaches have garnered attention and respect within the pharmaceutical community.

Collaborations

Some of his notable coworkers include Hiroki Mikami and Kazuharu Ienaga, who have collaborated with him on various research projects.

Conclusion

Ryoji Nishibata's contributions to pharmaceutical research, particularly in the area of asthma and allergic rhinitis, highlight his role as an important inventor in the field. His patents and collaborative efforts continue to pave the way for advancements in medical treatments.